Amwell® Announces Results for Third Quarter 2020
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Amwell (AMWL) Misses Q3 EPS by 64c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus
November 12, 2020 4:20 PM ESTAmwell (NYSE: AMWL) reported Q3 EPS of ($0.92), $0.64 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $62.55 million versus the consensus estimate of $55.77 million.
Total active providers of approximately 62,000 at the end of the third quarter increased 930% compared to a year agoTotal visits... More